Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Is ‘One to Watch’
February 29, 2024
Aston Bay Holdings (TSX.V: BAY) (OTCQB: ATBHF) is a publicly traded Canadian minerals exploration company focused on exploring high-grade copper and gold deposits in North America. The company owns the Storm Copper Project and the Seal Zinc Deposit in Nunavut, Canada, and is currently exploring the Buckingham Gold Vein and critical metals prospects in central […]
Venture Debt Market Rebounds as Deal Flows Surge
February 28, 2024
The collapse of Silicon Valley Bank (SVB last year had a significant impact on the venture debt market, resulting in a 44% year-over-year drop in early-stage lending during the first six months of 2023. Despite SVB’s failure, demand for venture debt remained strong. What was initially a major debt hole has since been filled by […]
InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Poised to Play Key Role Amidst ‘Historic Day for Cannabis in Germany’
February 26, 2024
Flora (NASDAQ: FLGC), a cannabis focused consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world, today issued an update to applaud the German parliament for voting in favor of legalizing cannabis for recreation use. After obtaining the first medical cannabis license in Germany, […]
GolfLync Inc. Proves Market-Fit and is Expanding
February 22, 2024
GolfLync has proven its success and is expanding to other markets! In an era where the intersection of technology and sports continues to redefine engagement, GolfLync(TM) stands out as a beacon of innovation and growth. With a user base that has surged to over 100,000 members and a platform supporting over 850 of Virtual Golf […]
UFC Phenom Marlon “Chito” Vera Dives Into The World of Infused Beverages With MAISON BLOOM
February 22, 2024
Vera Joins the Leader in Premium MALTernativeTM Beverages and Embraces Drinking Different SAN FRANCISCO, Feb. 21, 2024 (GLOBE NEWSWIRE) — via IBN – Marlon “Chito” Vera, renowned UFC fighter and entrepreneur, has taken a leap into the world of infused beverages and functional cannabinoid ready-to-drink beverages, joining MAISON BLOOM as part of his ongoing mission to share […]
InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Reports on Anticipated Timeline for Class 1 EV Cargo Vans CBP Ruling
February 21, 2024
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is reporting an update on its U.S. Customs and Border Protection (“CBP”) application for Class 1 EV cargo vans. According to the update, CBP notified counsel on Feb. 20, 2024, that a determination on the ruling request should be made in the next one to […]
Mullen Automotive Provides Timeline Update on US Customs and Border Protection Ruling for Class 1 EV Cargo Vans
February 21, 2024
BREA, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) — via IBN — Mullen Automotive Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, today announces an update on the U.S. Customs and Border Protection (“CBP”) application for Class 1 EV cargo vans. On Feb. 20, 2024, CBP informed counsel that a final determination on the […]
Diamond Lake Minerals Inc. (DLMI) Sees Fractional STO Ownership as a Solution to Real Estate Market Volatility and Insecurity
February 21, 2024
Recent concerns about a global wave of commercial real estate loan defaults, described as potentially the worst crisis for the sector since the 2008 bursting of the global financial bubble, is leading banks to proactively assure investors about their ability to absorb potential losses, while investors scrutinize loan books for signs of insecurity (https://ibn.fm/v5SpF). As […]
InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Eyes ‘Rarely Seen’ Clinically Significant Improvement in MS Patients
February 20, 2024
Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, recently reported new results from a long-term open-label extension (“LTE”) of the VISIONARY-MS trial in participants with stable relapsing multiple sclerosis (“RMS”) totaling nearly three years of […]
InvestorNewsBreaks – Battery Mineral Resources Corp. (TSX.V: BMR) (OTCQB: BTRMF) Closes Final Tranche of Private Placement
February 16, 2024
Battery Mineral Resources (TSX.V: BMR) (OTCQB: BTRMF) (“BMR”), a company providing shareholders exposure to the global megatrend of electrification while being focused on growth through cash flow, exploration and acquisitions in favorable mining jurisdictions, has closed the third and final tranche of a previously announced private placement of senior unsecured convertible debentures. The company raised […]
InvestorNewsBreaks — DoubleDown Interactive Co. Ltd. (NASDAQ: DDI) Releases Q4, FY 2023 Financial Report
February 14, 2024
DoubleDown Interactive (NASDAQ: DDI), a leading developer and publisher of digital games on mobile and web-based platforms, is reporting unaudited financial results for the fourth quarter and year ended December 31, 2023; that report includes contributions from European iGaming operator, SuprNation, which DoubleDown acquired in October 2023. Highlights of the report included $83.1 million revenue […]
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Holds Webinar to Discuss Positive Phase 3 Fibromyalgia Data, NDA Filing Plans
February 14, 2024
Tonix Pharmaceuticals Holding (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, recently held a key opinion leader (“KOL”) webinar hosted by Alliance Global Partners (“AGP”). The webinar featured two thought leaders in the field of fibromyalgia, Dr. Daniel Clauw and Dr. Lesley Arnold. The thought leaders discussed the positive […]
InvestorNewsBreaks – Battery Mineral Resources Corp. (TSX.V: BMR) (OTCQB: BTRMF) Partners with Javelin Global Commodities with Critical Agreements
February 13, 2024
Battery Mineral Resources (TSX.V: BMR) (OTCQB: BTRMF), a battery minerals company providing shareholders exposure to the global megatrend of electrification, and its Chilean subsidiary, Minera BMR SpA, have announced key agreements with Javelin Global Commodities. According to the announcement, the company entered into a marketing agreement, a master purchase and sale agreement, and a copper […]
Mullen Reports Strongest Fiscal Quarter in Company’s History for Three Months Ended Dec. 31, 2023
February 13, 2024
Mullen Automotive Inc. (NASDAQ: MULN), is updating its press release with certain corrections as described further below. There are no changes to the financial results for the three months ended Dec. 31, 2023. The prior press release as corrected is set forth in its entirety below. Company reports financial results and current business update Stockholders’ equity $271,814,097.00 […]
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) CEO Highlights Favorable Market Developments Creating New Opportunities
February 13, 2024
Vivos Therapeutics (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders, including all severities of obstructive sleep apnea (“OSA”) in adult patients, was spotlighted in a recent Proactive interview. During the interview, Vivos Therapeutics CEO Kirk Huntsman talked with Proactive […]
Clene Inc. (NASDAQ: CLNN) Revolutionizes Approach to Restore Neuronal Health in Neurodegenerative Disease with CNM-Au8(R)
February 13, 2024
Neurodegenerative diseases pose a significant challenge in healthcare, yet treatment options remain limited. Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, is working on a potentially groundbreaking nanomedicine called CNM-Au8® that aims to revolutionize the approach to addressing nervous system failure associated […]
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Notes Key Market Developments Resulting in Growth Opportunities
February 6, 2024
Vivos Therapeutics (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders, including all severities of obstructive sleep apnea (“OSA”) in adult patients, has noted significant favorable market developments resulting in opportunities for the company to reach out to more potential […]
InvestorNewsBreaks — DoubleDown Interactive Co. Ltd. (NASDAQ: DDI) Announces Plans to Release Financial Report, Schedules Earnings Call
January 31, 2024
DoubleDown Interactive (NASDAQ: DDI), a leading developer and publisher of digital games on mobile and web-based platforms, will release its Q4 2023 and FY 2023 financial results next month. The company plans to release the report market close on Feb. 13, 2024; the company will host a conference call and webcast at 5 p.m. ET […]
InvestorNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Granted US Patent Allowance for Key Technology Behind Lead Investigation Product
January 29, 2024
Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, has received notice from the United States Patent and Trademark Office (“USPTO”) of patent allowance for Medicinal Signaling Cells (“MSCs”). The patent covers the technology behind LGVN’s lead investigational product Lomecel-B(TM) and will impact patients with Aging-related Frailty receiving […]
Key Investor Conference Tips Shared by Managing Director of DealFlow Events in Recent Interview
January 22, 2024
Charlie Napolitano, Managing Director of DealFlow Events, was recently interviewed by The GotStocks Podcast. In addition to introducing DealFlow Events and its upcoming conference schedule, Charlie provided key insights on how to maximize success when attending investor events. A full transcript of the episode can be found below. To listen to the audio, please use […]
Clene Inc. (NASDAQ: CLNN) VISIONARY-MS Trial Data May Support CNM-Au8(R) as Long-Sought-After Multiple Sclerosis Treatment
January 22, 2024
Clene (NASDAQ: CLNN) and its wholly-owned subsidiary Clene Nanomedicine Inc., is a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”). The company recently reported new CNM-Au8(R) results from a long-term open-label extension (“LTE”) of the VISIONARY-MS trial in […]
GEMXX to Present at the Sequire Investor Summit in Puerto Rico
January 17, 2024
LAS VEGAS, Jan. 17, 2024 (GLOBE NEWSWIRE) — via IBN — GEMXX Corporation (OTC: GEMZ) (“GEMXX” or the “Company”), a leader in the ammolite gemstone mine-to-market segment, is proud to announce that it will be presenting at the upcoming Sequire Investor Summit 2024. This highly anticipated event, scheduled for Jan. 23-25, 2024, at Condado Vanderbilt Hotel in San Juan, Puerto […]
InvestorNewsBreaks – GEMXX Corporation (GEMZ) Announces Participation at Sequire Investor Summit in Puerto Rico
January 17, 2024
GEMXX (OTC: GEMZ), a leader in the ammolite gemstone mine-to-market segment, will be presenting at this month’s Sequire Investor Summit 2024. Sequire Investor Summit: Puerto Rico is slated for Jan. 23–25, 2024, in San Juan. According to the announcement, the three-day event is designed to provide an array of exciting opportunities for funds, companies and […]
Mullen Automotive Provides 2023 Financial Results and Current Business Update
January 17, 2024
BREA, Calif., Jan. 16, 2024 (GLOBE NEWSWIRE) — via IBN – Mullen Automotive Inc. (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announces financial results for the twelve months ended Sept. 30, 2023, and a current business update. Commenting on fiscal year 2023 (“FY2023”) and recent Company developments, CEO and chairman David Michery stated, “Mullen has initiated […]
InvestorNewsBreaks – Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) Expands Exploration Rights at PCH Rare Earths Ionic Adsorption Clay Project
January 11, 2024
Appia (CSE: API) (OTCQX: APAAF) (FSE: A0I0) today announced the extension of its existing mining claims at the PCH project in Goiás, Brazil from 17,551.07 hectares to an expansive 40,963.18 hectares across a total of 22 claim blocks. The substantial 133% increase in the current land package includes 12 new claims independently staked by Appia, […]
InvestorNewsBreaks — DoubleDown Interactive Co. Ltd. (NASDAQ: DDI) Announces Participation in Upcoming Needham Growth Conference
January 10, 2024
DoubleDown Interactive (NASDAQ: DDI), a leading developer and publisher of digital games on mobile and web-based platforms, announced that it will be participating in the upcoming Needham Growth Conference. According to the announcement, Joe Sigrist, DDI’s chief financial officer, is schedule to present at the event, which is scheduled for Jan. 18, 2024. Sigrist’s presentation […]
Mullen Submits Grant Funding Opportunity to DOE for Domestic Battery Materials Processing
January 8, 2024
Company plans to produce an estimated 150,000 battery packs through 2032 Program to provide $3.5 billion to strengthen US battery material manufacturing (DE-FOA-0003099) BREA, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) — via IBN — Mullen Automotive, Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, today announces its subsidiary Mullen Advanced Energy, LLC […]
Sigyn Therapeutics Inc. (SIGY) Is ‘One to Watch’
January 8, 2024
Sigyn Therapeutics (OTCQB: SIGY, SIGYD) is a development-stage medical technology company headquartered in San Diego, California. The company’s therapeutic candidates include Sigyn Therapy(TM) to address pathogen-associated inflammatory disorders, the ImmunePrep(TM) platform to enhance the performance of immunotherapeutic antibodies, ChemoPrep(TM) to improve the delivery of cancer chemotherapy and ChemoPure(TM) to reduce the toxicity of chemotherapy. Sigyn […]
InvestorNewsBreaks — DoubleDown Interactive Co. Ltd. (NASDAQ: DDI) Announces Participation in Upcoming iAccess Alpha Virtual MicroCap Conference
January 5, 2024
DoubleDown Interactive (NASDAQ: DDI), a leading developer and publisher of digital games on mobile and web-based platforms, will be represented at next week’s iAccess Alpha Virtual MicroCap Conference. The two-day, online event will be held Jan. 9–10, 2024. According to the announcement, DoubleDown Interactive CFO Joe Sigrist will attend the conference and is also scheduled […]
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Eyes Enormous Opportunities Across Its Clinical Development Programs
January 4, 2024
Cybin (NYSE American: CYBN) (NEO: CYBN) is a clinical-stage biopharmaceutical company committed to revolutionizing mental health care by developing new and innovative next-generation psychedelic-based treatment options. The company today outlined its recent positive Phase 2 CYB003 topline results in MDD and near-term milestones across its clinical-stage deuterated psilocybin and dDMT programs in development for the […]
InvestorNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Announces Dosing of First Patient in Phase 2a TRP-8802 Clinical Trial
January 4, 2024
Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) is a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical needs. The company today announced that the first patient has been dosed in a phase 2a clinical trial evaluating Tryp’s TRP-8802 in patients with fibromyalgia, which is being […]
Clene Inc.’s (NASDAQ: CLNN) Phase 2 REPAIR-PD and REPAIR-MD Trials Indicate CNM-Au8(R)’s Ability to Increase Key Brain Metabolites, Supporting Advancement to Phase 3 Trials
January 2, 2024
Energy metabolism involves the conversion of the potential energy contained in food-borne fuels, including some amino acids, glucose, lactate, fatty acids, and ethanol, among others, into chemical energy. Usually, this chemical energy exists in the form of adenosine triphosphate (“ATP”), the universal energy-containing molecule that powers most cellular functions, including brain function. ATP is produced […]
HEMP BioSciences Inc. a Wholly-owned Division of WEED Inc. Receives Full Suite of Industrial Hemp Licenses From State of Arizona
December 21, 2023
TUCSON, Ariz., Dec. 21, 2023 (GLOBE NEWSWIRE) — via IBN – WEED Inc. (OTCQB: BUDZ), (“WEED,” “HEMP” or the “Company”), a global cannabis and hemp bioresearch company based in the U.S. focused on the development and application of cannabis–derived compounds for the treatment of human and animal diseases, announces today that it intends to expand into consumer […]
HEMP BioSciences Inc. a Wholly-owned Division of WEED Inc. Receives Full Suite of Industrial Hemp Licenses From State of Arizona
December 21, 2023
WEED Inc. subsidiary will begin buildout of its cGMP certified kitchen to begin manufacturing of consumer-packaged goods TUCSON, Ariz., Dec. 21, 2023 (GLOBE NEWSWIRE) — via IBN – WEED Inc. (OTCQB: BUDZ), (“WEED,” “HEMP” or the “Company”), a global cannabis and hemp bioresearch company based in the U.S. focused on the development and application of […]
Mullen CEO Addresses Letter to Shareholders
December 19, 2023
BREA, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) — via IBN — Mullen Automotive, Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, today shares an open letter to Mullen shareholders addressing its recent reverse stock split. Dear Mullen Shareholders: As most of you are aware by now, at the recently reconvened shareholders meeting […]
InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Lead Drug Candidate Featured in Peer-Reviewed Publication Describing Brain Target Engagement in Neurodegenerative Diseases
December 14, 2023
Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”), Parkinson’s disease and multiple sclerosis (“MS”), along with subsidiary Clene Nanomedicine, is announcing the publication of a peer-reviewed article describing brain target engagement by CNM-Au8(R), the company’s lead drug […]
InvestorNewsBreaks – Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF) Comments on Steadfast Commitment to Guyana
December 11, 2023
Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF) today commented on the border controversy between the Co-operative Republic of Guyana and the Bolivarian Republic of Venezuela following a consultative referendum held last week. The internationally recognized border between Venezuela and Guyana was established on Oct. 3, 1899, by an arbitration panel. In 1962, Venezuela claimed that the […]
InvestorNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Inks Definitive Agreement with Exopharm Limited
December 11, 2023
Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical needs, has signed a definitive agreement with Exopharm Limited ACN 163 765 991. The agreement, signed last week, outlines plans for Exopharm to acquire all issued and outstanding common […]
InvestorNewsBreaks – Battery Mineral Resources Corp. (TSX.V: BMR) (OTCQB: BTRMF) Issues Operations, Permitting and Community Relations Update
December 5, 2023
Battery Mineral Resources (TSX.V: BMR) (OTCQB: BTRMF) (“BMR”), a battery minerals company providing shareholders exposure to the global megatrend of electrification while being focused on growth through cash flow, exploration and acquisitions in favorable mining jurisdictions, today provided an operational, permit and community relations update. Among the highlights, the company reported that personnel hiring for […]
InvestorNewsBreaks – Laredo Oil Inc. (LRDC) Announces Discovery of Free Oil in Connection with Lustre, Texakoma Agreement
December 5, 2023
Laredo Oil (OTC: LRDC), an exploration and production company, today announced the discovery of “free oil” in the second of two wells drilled by Texakoma Exploration and Production, LLC under the agreement between Lustre Oil Company, LLC (a wholly owned subsidiary of Laredo Oil) and Texakoma. Similar to the first well drilled under the agreement, […]